Test Code TAPNS Tapentadol and Metabolite, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (Serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1.0 mL Serum
Collection Instructions: Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.
Useful For
Monitoring medication compliance in patients who are prescribed tapentadol
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Tapentadol and Metabolite, SSpecimen Type
Serum RedSpecimen Minimum Volume
Serum: 0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum Red | Refrigerated (preferred) | 14 days |
| Frozen | 28 days | |
| Ambient | 14 days |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | OK |
| Gross icterus | OK |
Clinical Information
Tapentadol is a centrally acting opioid analgesic which is utilized in the treatment of moderate to moderately severe pain. This drug is rapidly absorbed and has dual mechanism of action, combining mu-opioid receptor agonism with noradrenaline reuptake inhibition in the same molecule. The primary metabolite of tapentadol is N-desmethyltapentadol. The test will be primarily used by physicians to determine if patients are compliant with the medication.
Reference Values
Tapentadol:
Therapeutic: 5-300 ng/mL
N-desmethyltapentadol:
No therapeutic range established
Cutoff concentrations by liquid chromatography tandem mass spectrometry:
Tapentadol: 0.5 ng/mL
N-desmethyltapentadol: 0.5 ng/mL
Interpretation
Serum concentrations for pain relief typically fall in the range of 5-300 ng/mL, but depend heavily on dose, frequency, and individual patient factors.
Cautions
Specimens collected in serum gel tubes are not acceptable because the drug can absorb onto the gel and lead to falsely decreased concentrations.
Method Description
Serum samples are mixed with internal standard and extracted by protein crash with methanol. The supernatant after centrifugation is diluted with Clinical Laboratory Reagent Water. The sample is then analyzed by liquid chromatography tandem mass spectrometer.(Unpublished Mayo method)
Day(s) Performed
Tuesday
Report Available
3 to 7 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TAPNS | Tapentadol and Metabolite, S | In Process |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 624021 | Tapentadol | 59354-1 |
| 624022 | N-desmethyltapentadol | In Process |